Larouche Danielle, Cantin-Warren Laurence, Desgagné Maxime, Guignard Rina, Martel Israël, Ayoub Akram, Lavoie Amélie, Gauvin Robert, Auger François A, Moulin Véronique J, Germain Lucie
Département de Chirurgie, Faculté de Médecine, Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, Université Laval, Québec, Canada.; Centre de Recherche du CHU de Québec-Université Laval, Axe Médecine Régénératrice, Québec, Canada.
Département de Chirurgie, Faculté de Médecine, Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX, Université Laval, Québec, Canada.; Centre de Recherche du CHU de Québec-Université Laval, Axe Médecine Régénératrice, Québec, Canada.; Centre Québécois sur les Matériaux Fonctionnels (CQMF), Québec, Canada.
Biores Open Access. 2016 Nov 1;5(1):320-329. doi: 10.1089/biores.2016.0036. eCollection 2016.
There is a clinical need for skin substitutes to replace full-thickness skin loss. Our group has developed a bilayered skin substitute produced from the patient's own fibroblasts and keratinocytes referred to as Self-Assembled Skin Substitute (SASS). After cell isolation and expansion, the current time required to produce SASS is 45 days. We aimed to optimize the manufacturing process to standardize the production of SASS and to reduce production time. The new approach consisted in seeding keratinocytes on a fibroblast-derived tissue sheet before its detachment from the culture plate. Four days following keratinocyte seeding, the resulting tissue was stacked on two fibroblast-derived tissue sheets and cultured at the air-liquid interface for 10 days. The resulting total production time was 31 days. An alternative method adapted to more contractile fibroblasts was also developed. It consisted in adding a peripheral frame before seeding fibroblasts in the culture plate. SASSs produced by both new methods shared similar histology, contractile behavior and evolution after grafting onto mice when compared with SASSs produced by the 45-day standard method. In conclusion, the new approach for the production of high-quality human skin substitutes should allow an earlier autologous grafting for the treatment of severely burned patients.
临床需要皮肤替代物来替代全层皮肤缺损。我们团队研发了一种双层皮肤替代物,它由患者自身的成纤维细胞和角质形成细胞制成,称为自组装皮肤替代物(SASS)。在细胞分离和扩增后,目前生产SASS所需的时间为45天。我们旨在优化制造工艺,使SASS的生产标准化并缩短生产时间。新方法是在角质形成细胞从培养板上脱离之前,将其接种在成纤维细胞衍生的组织片上。接种角质形成细胞四天后,将所得组织堆叠在两片成纤维细胞衍生的组织片上,并在气液界面培养10天。最终的总生产时间为31天。还开发了一种适用于收缩性更强的成纤维细胞的替代方法。该方法是在将成纤维细胞接种到培养板之前添加一个周边框架。与通过45天标准方法生产的SASS相比,两种新方法生产的SASS在组织学、收缩行为以及移植到小鼠后的演变方面具有相似性。总之,生产高质量人类皮肤替代物的新方法应能使严重烧伤患者更早地进行自体移植治疗。